209 related articles for article (PubMed ID: 38740620)
1. Conservative treatment of Peyronie's disease: a guide.
Cosentino M; Di Nauta M; Boeri L; Ferraioli G; Lucignani G; Ricapito A; Gadda F; Iafrate M; Mancini M; Dal Moro F; Ruiz-Castañe E; Bettocchi C; Montanari E; Sofikitis N
World J Urol; 2024 May; 42(1):317. PubMed ID: 38740620
[TBL] [Abstract][Full Text] [Related]
2. Conservative Therapy for Peyronie's Disease: a Contemporary Review of the Literature.
Yousif A; Natale C; Hellstrom WJG
Curr Urol Rep; 2021 Jan; 22(2):6. PubMed ID: 33420664
[TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature.
Russo GI; Milenkovic U; Hellstrom W; Levine LA; Ralph D; Albersen M
Eur Urol; 2018 Dec; 74(6):767-781. PubMed ID: 30237020
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.
Cocci A; Cito G; Urzì D; Minervini A; Di Maida F; Sessa F; Mari A; Campi R; Falcone M; Capece M; Morelli G; Cacciamani G; Rizzo M; Polito C; Giammusso B; Morgia G; Verze P; Salonia A; Cai T; Mirone V; Mondaini N; Russo GI
J Sex Med; 2018 Oct; 15(10):1472-1477. PubMed ID: 30245025
[TBL] [Abstract][Full Text] [Related]
5. NON-SURGICAL TREATMENT OF PEYRONIE'S DISEASE: A COMPREHENSIVE REVIEW.
Chernylovskyi VA; Krakhotkin DV; Chaikovskyi VP
Wiad Lek; 2021; 74(3 cz 1):539-545. PubMed ID: 33813465
[TBL] [Abstract][Full Text] [Related]
6. Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment.
Wymer K; Kohler T; Trost L
J Sex Med; 2019 Sep; 16(9):1421-1432. PubMed ID: 31351851
[TBL] [Abstract][Full Text] [Related]
7. Technological Advancements for Treating Erectile Dysfunction and Peyronie's Disease.
Campbell JD; Matti D; Abed H; Di Pierdominico A
Urol Clin North Am; 2022 Feb; 49(1):175-184. PubMed ID: 34776050
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.
Ralph DJ; Abdel Raheem A; Liu G
J Sex Med; 2017 Nov; 14(11):1430-1437. PubMed ID: 28974406
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase clostridium Histolyticum for Peyronie's Disease.
Goldstein I; Lipshultz LI; McLane M; Hu Y; Xiang Q; Liu G; Vijayan S; Gelbard MK
J Urol; 2020 Jun; 203(6):1191-1197. PubMed ID: 31922462
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Combined Collagenase Clostridium histolyticum and RestoreX Penile Traction Therapy in Men with Peyronie's Disease.
Alom M; Sharma KL; Toussi A; Kohler T; Trost L
J Sex Med; 2019 Jun; 16(6):891-900. PubMed ID: 30956106
[TBL] [Abstract][Full Text] [Related]
11. Peyronie's disease: pharmacological treatments and limitations.
Li EV; Esterquest R; Pham MN; Panken EJ; Amarasekera C; Siebert A; Bajic P; Levine LA
Expert Rev Clin Pharmacol; 2021 Jun; 14(6):703-713. PubMed ID: 33719851
[No Abstract] [Full Text] [Related]
12. Intralesional Collagenase Clostridium histolyticum Causes Meaningful Improvement in Men with Peyronie's Disease: Results of a Multi-Institutional Analysis.
Hellstrom WJG; Tue Nguyen HM; Alzweri L; Chung A; Virasoro R; Tapscott A; Ziegelmann M; Trost L; Gelbard M
J Urol; 2019 Apr; 201(4):777-782. PubMed ID: 30672843
[TBL] [Abstract][Full Text] [Related]
13. Shockwave Therapy in the Treatment of Peyronie's Disease.
Krieger JR; Rizk PJ; Kohn TP; Pastuszak A
Sex Med Rev; 2019 Jul; 7(3):499-507. PubMed ID: 30926460
[TBL] [Abstract][Full Text] [Related]
14. Review of Management Options for Active-Phase Peyronie's Disease.
Brimley SC; Yafi FA; Greenberg J; Hellstrom WJG; Tue Nguyen HM; Hatzichristodoulou G
Sex Med Rev; 2019 Apr; 7(2):329-337. PubMed ID: 30503796
[TBL] [Abstract][Full Text] [Related]
15. Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.
Levine LA; Larsen SM
J Sex Med; 2015 Jan; 12(1):259-64. PubMed ID: 25345351
[TBL] [Abstract][Full Text] [Related]
16. Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.
Levine LA; Cuzin B; Mark S; Gelbard MK; Jones NA; Liu G; Kaufman GJ; Tursi JP; Ralph DJ
J Sex Med; 2015 Jan; 12(1):248-58. PubMed ID: 25388099
[TBL] [Abstract][Full Text] [Related]
17. Peyronie's disease: clinical treatment.
Aita G; Ros CTD; Silvinato A; Bernardo WM
Rev Assoc Med Bras (1992); 2019; 65(10):1231-1239. PubMed ID: 31721953
[No Abstract] [Full Text] [Related]
18. Peyronie's disease: new paradigm for the treatment of a unique cause of erectile dysfunction.
Carson C
Postgrad Med; 2020 Dec; 132(sup4):4-8. PubMed ID: 33156731
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of local injections treatments for Peyronie's disease: Review of the literature].
Rod X; Akakpo W; Roupret M
Prog Urol; 2021 Dec; 31(16):1072-1079. PubMed ID: 34148769
[TBL] [Abstract][Full Text] [Related]
20. Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease.
Ziegelmann MJ; Viers BR; McAlvany KL; Bailey GC; Savage JB; Trost LW
J Urol; 2016 Apr; 195(4 Pt 1):1051-6. PubMed ID: 26476353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
